Literature DB >> 22529718

Effectiveness and cost-benefit of an influenza vaccination program for health care workers.

A Yassi1, J Kettner, G Hammond, M Cheang, M McGill.   

Abstract

This study retrospectively reviewed the effectiveness of a vaccination program for hospital workers in a large tertiary care hospital, quantified influenza-induced absenteeism, and examined the factors determining the costs and benefits of this program. Absenteeism among high risk hospital workers was increased by 35% (P=0.001) during the virulent influenza epidemic of 1987-88. Benefits, measured as the value of sick time avoided, compared with costs, including materials, occupational nursing staff time, employee time during vaccination, and time lost due to adverse reactions, revealed a net benefit of $39.23 per vaccinated employee. Sensitivity analyses highlighted vaccine efficacy and absenteeism due to influenza and adverse reactions to vaccination as the most important factors; with time lost due to adverse reactions as much as 0.013 days per vaccinated employee and a vaccine efficacy of 70%, net positive benefits could be achieved if influenza-induced absenteeism is 0.5% or greater of paid employee time during the epidemic season. The results suggested that the net cost-benefit of a hospital employee vaccination program to decrease both employee morbidity and nosocomial influenza among patients, would be increased by active promotion of the vaccination program, especially for employees in high risk areas.

Entities:  

Keywords:  Cost-benefit; Hospital workers; Influenza vaccine

Year:  1991        PMID: 22529718      PMCID: PMC3328002          DOI: 10.1155/1991/376502

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  16 in total

1.  Prevention and control of influenza. Recommendations of the Immunization Practices Advisory Committee (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1990-05-11

2.  Nosocomial influenza A infection.

Authors:  B A McDougal; G R Hodges; H D Lewis; J W Davis; S A Caldwell
Journal:  South Med J       Date:  1977-08       Impact factor: 0.954

3.  Influenza and pneumococcal immunization strategies for physicians.

Authors:  D S Fedson
Journal:  Chest       Date:  1987-03       Impact factor: 9.410

4.  Hong Kong influenza in a neonatal unit.

Authors:  C R Bauer; K Elie; L Spence; L Stern
Journal:  JAMA       Date:  1973-03-12       Impact factor: 56.272

5.  Prevention of nosocomial influenza infection with Amantadine.

Authors:  J M O'Donoghue; C G Ray; D W Terry; H N Beaty
Journal:  Am J Epidemiol       Date:  1973-04       Impact factor: 4.897

6.  Influenza A among hospital personnel and patients. Implications for recognition, prevention, and control.

Authors:  C T Pachucki; S A Pappas; G F Fuller; S L Krause; J R Lentino; D M Schaaff
Journal:  Arch Intern Med       Date:  1989-01

7.  Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis.

Authors:  G W Hammond; M Cheang
Journal:  Can Med Assoc J       Date:  1984-09-01       Impact factor: 8.262

8.  Achieving the national health objective for influenza immunization: success of an institution-wide vaccination program.

Authors:  K L Nichol; J E Korn; K L Margolis; G A Poland; R A Petzel; R P Lofgren
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

9.  Evaluation of adverse events after influenza vaccination in hospital personnel.

Authors:  D W Scheifele; G Bjornson; J Johnston
Journal:  CMAJ       Date:  1990-01-15       Impact factor: 8.262

10.  Influenza vaccination.

Authors:  M A Riddiough; J E Sisk; J C Bell
Journal:  JAMA       Date:  1983-06-17       Impact factor: 56.272

View more
  13 in total

1.  Economic evaluations of influenza vaccination in healthy working-age adults. Employer and society perspective.

Authors:  S C Wood; V H Nguyen; C Schmidt
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

Review 2.  Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.

Authors:  Maarten J Postma; Paul Jansema; Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager; Lolkje T W de Jong-van den Berg
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac in the UK.

Authors:  Roben Das Gupta; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities.

Authors:  Akiko C Kimura; Christine N Nguyen; Jeffrey I Higa; Eric L Hurwitz; Duc J Vugia
Journal:  Am J Public Health       Date:  2007-02-28       Impact factor: 9.308

5.  Influenza vaccination for health care workers: A duty of care.

Authors:  P Orr
Journal:  Can J Infect Dis       Date:  2000-09

Review 6.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

7.  Morbidity, cost and role of health care worker transmission in an influenza outbreak in a tertiary care hospital.

Authors:  A Yassi; M McGill; D Holton; L Nicolle
Journal:  Can J Infect Dis       Date:  1993-01

8.  Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?

Authors:  C G Stevenson; M A McArthur; M Naus; E Abraham; A J McGeer
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

9.  Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics.

Authors:  Maria Michela Gianino; Gianfranco Politano; Antonio Scarmozzino; Lorena Charrier; Marco Testa; Sebastian Giacomelli; Alfredo Benso; Carla Maria Zotti
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

10.  Vaccination coverage for seasonal influenza among residents and health care workers in Norwegian nursing homes during the 2012/13 season, a cross-sectional study.

Authors:  Horst Bentele; Marianne R Bergsaker; Siri Helene Hauge; Jørgen V Bjørnholt
Journal:  BMC Public Health       Date:  2014-05-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.